Hostname: page-component-89b8bd64d-x2lbr Total loading time: 0 Render date: 2026-05-07T19:07:49.802Z Has data issue: false hasContentIssue false
  • English
  • Français

Crystal structure of alectinib hydrochloride Type I, C30H35N4O2Cl

Published online by Cambridge University Press:  20 May 2024

James A. Kaduk Open the ORCID record for James A. Kaduk [Opens in a new window] ,
Megan M. Rost ,
Anja Dosen Open the ORCID record for Anja Dosen [Opens in a new window]  and
Thomas N. Blanton Open the ORCID record for Thomas N. Blanton [Opens in a new window]
James A. Kaduk*
Affiliation:
Illinois Institute of Technology, 3101 S. Dearborn St., Chicago, IL 60616, USA North Central College, 131 S. Loomis St., Naperville, IL 60540, USA
Megan M. Rost
Affiliation:
ICDD, 12 Campus Blvd., Newtown Square, PA 19073-3273, USA
Anja Dosen
Affiliation:
ICDD, 12 Campus Blvd., Newtown Square, PA 19073-3273, USA
Thomas N. Blanton
Affiliation:
ICDD, 12 Campus Blvd., Newtown Square, PA 19073-3273, USA
*
a)Author to whom correspondence should be addressed. Electronic mail: kaduk@polycrystallography.com

Abstract

The crystal structure of alectinib hydrochloride has been solved and refined using synchrotron X-ray powder diffraction data and optimized using density functional theory techniques. Alectinib hydrochloride crystallizes in space group P21/n (#14) with the following parameters: a = 12.67477(7), b = 10.44076(5), c = 20.38501(12) Å, β = 93.1438(7)°, V = 2693.574(18) Å3, and Z = 4 at 295 K. The crystal structure consists of stacks of molecules along the b-axis, and the stacks contain chains of strong N–H⋯Cl hydrogen bonds. One density functional theory calculation moved a proton from an N atom to the Cl, but another calculation yielded a more chemically reasonable result. The powder pattern has been submitted to ICDD for inclusion in the Powder Diffraction File™ (PDF®)

Keywords

alectinibAlcensa®crystal structureRietveld refinementdensity functional theory

Information

Type
New Diffraction Data
Information
Powder Diffraction , Volume 39 , Issue 3 , September 2024 , pp. 170 - 175
Check for updates
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited
Copyright
Copyright © The Author(s), 2024. Published by Cambridge University Press on behalf of International Centre for Diffraction Data

In memory of Earle R. Ryba of The Pennsylvania State University

I. INTRODUCTION

Alectinib hydrochloride (marketed under the trade name Alcensa®) is used to treat non-small-cell-lung cancer that has spread to other parts of the body (metastasis). The systematic name of alectinib hydrochloride (CAS Registry Number 1256589-74-8) is 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5H-benzo[b]carbazole-3-carbonitrile hydrochloride. A two-dimensional molecular diagram of alectinib hydrochloride is shown in Figure 1.

Figure 1.

The two-dimensional structure of alectinib hydrochloride.

X-ray powder diffraction data are reported for crystalline Type I of alectinib hydrochloride in European Patent EP3135671 B1 (Tanaka and Ueto, Reference Tanaka and Ueto2019; Chugai Seiyaku Kabushiki Kaisha), and Type II and Type III are claimed (Figure 2). The crystal structures have not yet been reported. A process for preparing alectinib hydrochloride and Types IV, V, and VI are claimed in International Patent Application WO2019/008520 A1 (Tomar et al., Reference Tomar, Azim, Gupta, Lahiri and Cabri2019; Fresenius Kabi Oncology Ltd.) and its US equivalent US 2020/0140427 A1 (Tomar et al., Reference Tomar, Azim, Gupta, Lahiri and Cabri2020). These Fresenius applications also claim a process for preparing alectinib free base and crystalline Form B of alectinib.

Figure 2.

X-ray powder diffraction patterns of crystalline Type I (black), II (green), and III (red) of alectinib hydrochloride from European Patent EP3135671 B1 (Tanaka and Ueto, Reference Tanaka and Ueto2019; Chugai Seiyaku Kabushiki Kaisha). The patent patterns (measured using Cu Kα radiation) were digitized using UN-SCAN-IT (Silk Scientific, 2013). The image is generated using JADE Pro (MDI, 2023).

This work was carried out as part of a project (Kaduk et al., Reference Kaduk, Crowder, Zhong, Fawcett and Suchomel2014) to determine the crystal structures of large-volume commercial pharmaceuticals and include high-quality powder diffraction data for them in the Powder Diffraction File (Gates-Rector and Blanton, Reference Gates-Rector and Blanton2019).

II. EXPERIMENTAL

Alectinib hydrochloride used in this study was a commercial reagent, purchased from TargetMol (Batch #142717), and was used as-received. The white powder was packed into a 1.5 mm diameter Kapton capillary and rotated during the measurement at ~50 Hz. The powder pattern was measured at 295 K at beamline 11-BM (Antao et al., Reference Antao, Hassan, Wang, Lee and Toby2008; Lee et al., Reference Lee, Shu, Ramanathan, Preissner, Wang, Beno, Von Dreele, Ribaud, Kurtz, Antao, Jiao and Toby2008; Wang et al., Reference Wang, Toby, Lee, Ribaud, Antao, Kurtz, Ramanathan, Von Dreele and Beno2008) of the Advanced Photon Source at Argonne National Laboratory using a wavelength of 0.459744(2) Å from 0.5 to 40° 2θ with a step size of 0.001° and a counting time of 0.1 s/step. The high-resolution powder diffraction data were collected using 12 silicon crystal analyzers that allow for high angular resolution, high precision, and accurate peak positions. A mixture of silicon (NIST SRM 640c) and alumina (NIST SRM 676a) standards (ratio Al2O3:Si = 2:1 by weight) was used to calibrate the instrument and refine the monochromatic wavelength used in the experiment.

The pattern was indexed using JADE Pro (MDI, 2023) on a primitive monoclinic unit cell with the following parameters: a = 12.66430, b = 10.43968, c = 20.37822 Å, β = 93.21°, V = 2690.00 Å3, and Z = 4. The space group suggested by EXPO2014 (Altomare et al., Reference Altomare, Cuocci, Giacovazzo, Moliterni, Rizzi, Corriero and Falcicchio2013) was P2 1/n, which was confirmed by the successful solution and refinement of the structure. A reduced cell search of the Cambridge Structural Database (Groom et al., Reference Groom, Bruno, Lightfoot and Ward2016) yielded 14 hits, but none were structures of alectinib derivatives.

The alectinib molecule was downloaded from PubChem (Kim et al., Reference Kim, Chen, Cheng, Gindulyte, He, He, Li, Shoemaker, Thiessen, Yu, Zaslavsky, Zhang and Bolton2023) as Conformer3D_CID_49806720.sdf and was converted into a .mol2 file using Mercury (Macrae et al., Reference Macrae, Sovago, Cottrell, Galek, McCabe, Pidcock, Platings, Shields, Stevens, Towler and Wood2020). The structure was solved by Monte Carlo-simulated annealing techniques as implemented in EXPO2014 (Altomare et al., Reference Altomare, Cuocci, Giacovazzo, Moliterni, Rizzi, Corriero and Falcicchio2013) using an alectinib molecule and a Cl atom as fragments. Analysis of potential hydrogen bond interactions made it clear that N5 was protonated, and H72 was added to that atom using Materials Studio (Dassault, 2022).

Rietveld refinement was carried out with GSAS-II (Toby and Von Dreele, Reference Toby and Von Dreele2013). Only the 2.0–25.0° 2θ portion of the pattern was included in the refinements (d min = 1.062 Å). All non-H-bond distances and angles were subjected to restraints based on a Mercury/Mogul Geometry Check (Bruno et al., Reference Bruno, Cole, Kessler, Luo, Motherwell, Purkis, Smith, Taylor, Cooper, Harris and Orpen2004; Sykes et al., Reference Sykes, McCabe, Allen, Battle, Bruno and Wood2011). The Mogul average and standard deviation for each quantity were used as the restraint parameters. The benzene and fused 5/6 rings were restrained to be planar. The restraints contributed 5.8% to the final χ 2. The hydrogen atoms were included in calculated positions, which were recalculated during the refinement using Materials Studio (Dassault, 2022). The U iso of the C, N, and O atoms were grouped by chemical similarity. The Cl atom was refined anisotropically. The U iso values for the H atoms were fixed at 1.3× the U iso values of the heavy atoms to which they are attached. The peak profiles were described using the generalized microstrain model (Stephens, Reference Stephens1999). The background was modeled using a 6-term shifted Chebyshev polynomial, with a peak at 5.87° 2θ to describe the scattering from the Kapton capillary and an amorphous component.

The final refinement of 145 variables using 23,037 observations and 105 restraints yielded the residuals R wp = 0.08848 and goodness of fit = 1.16. The largest peak (0.23 Å from C25) and hole (1.63 Å from O2) in the difference Fourier map were 0.20(5) and –0.23(5) eÅ−3, respectively. The final Rietveld plot is shown in Figure 3. The largest features in the normalized error plot are very small and represent subtle errors in peak shapes.

Figure 3.

The Rietveld plot for the refinement of alectinib hydrochloride. The blue crosses represent the observed data points, and the green line is the calculated pattern. The cyan curve is the normalized error plot, and the red line is the background curve. The vertical scale has been multiplied by a factor of 20× for 2θ > 15.0°.

A default geometry optimization of the alectinib hydrochloride crystal structure using Vienna Ab Initio Structure Package (VASP) (Kresse and Furthmüller, Reference Kresse and Furthmüller1996) through the MedeA graphical interface (Materials Design, 2016) moved H72 from N5 to Cl71. Higher-level calculations using more k-points and/or a higher energy cutoff yielded the same chemically unreasonable result. A geometry optimization (fixed experimental cell) and population analysis were carried out using CRYSTAL23 (Erba et al., Reference Erba, Desmarais, Casassa, Civalleri, Donà, Bush, Searle, Maschio, Daga, Cossard, Ribaldone, Ascrizzi, Marana, Flament and Kirtman2023). The 6-31d1G basis sets for the H, C, N, and O atoms in the calculation were those of Gatti et al. (Reference Gatti, Saunders and Roetti1994), and the triple-zeta basis set for Cl was that of Peintinger et al. (Reference Peintinger, Vilela Oliveira and Bredow2013). The calculations were run on a 3.5 GHz PC using 8 k-points and the B3LYP functional and took ~14.5 days.

III. RESULTS AND DISCUSSION

The powder pattern of the alectinib hydrochloride measured here agrees well enough with that reported for Type I (Tanaka and Ueto, Reference Tanaka and Ueto2019; Chugai Seiyaku Kabushiki Kaisha) to conclude that they represent the same material (Figure 4). The asymmetric unit contains one alectinib cation and one chloride anion (Figure 5).

Figure 4.

Comparison of the synchrotron pattern of alectinib hydrochloride from this study (black) to that of Form I from European Patent EP3135671 B1 (Tanaka and Ueto, Reference Tanaka and Ueto2019; Chugai Seiyaku Kabushiki Kaisha, green). The patent pattern (measured using Cu Kα radiation) was digitized using UN-SCAN-IT (Silk Scientific, 2013) and converted to the synchrotron wavelength of 0.459744 Å using JADE Pro (MDI, 2023). The image is generated using JADE Pro (MDI, 2023).

Figure 5.

The asymmetric unit of alectinib hydrochloride is depicted, with the atom numbering included. The atoms are represented by 50% probability spheroids/ellipsoids. The image is generated using Mercury (Macrae et al., Reference Macrae, Sovago, Cottrell, Galek, McCabe, Pidcock, Platings, Shields, Stevens, Towler and Wood2020).

The root-mean-square Cartesian displacement of the non-H atoms in the Rietveld-refined and CRYSTAL23-optimized cation structures is 0.181 Å (Figure 6); the maximum deviation is 0.419 Å at N5. The orientations of the methyl groups differ in the refined and optimized structures, but the final H positions in the refined structure were determined by a force field; the difference with the full density functional theory (DFT) optimization is not significant. The absolute position difference between the Cl71 in the refined and optimized structures is 0.704 Å. The agreement of the cations is within the normal range for correct structures (van de Streek and Neumann, Reference van de Streek and Neumann2014) and confirms that the structure is correct. The agreement of the anion position is outside the typical range for correct organic structures but is not uncommon for inorganic anions. The chemically unreasonable VASP optimization provides a good reminder that DFT calculations are not always correct. The reminder of this discussion will emphasize the CRYSTAL23-optimized structure.

Figure 6.

Comparison of the Rietveld-refined (red) and CRYSTAL23-optimized (blue) structures of alectinib hydrochloride. The rms Cartesian displacement for the cation is 0.181 Å. The image is generated using Mercury (Macrae et al., Reference Macrae, Sovago, Cottrell, Galek, McCabe, Pidcock, Platings, Shields, Stevens, Towler and Wood2020).

Almost all of the bond distances and bond angles fall within the normal ranges indicated by a Mercury Mogul Geometry check (Macrae et al., Reference Macrae, Sovago, Cottrell, Galek, McCabe, Pidcock, Platings, Shields, Stevens, Towler and Wood2020). The C15–N5 distance of 1.476 Å (average = 1.352(16) Å, Z-score = 4.7) is flagged as unusual. The C35–C32–C30 angle of 116.2° (average = 119.5(5)°, Z-score = 6.2) is also flagged as unusual. The high Z-score results from the exceptionally low standard uncertainty on the average. No hits were found for the C12–C15–N5 and C21–C15–N5 angles.

Quantum chemical geometry optimization of the isolated cation (DFT/B3LYP/6-31G*/water) using Spartan ‘20 (Wavefunction, 2022) indicated that the solid-state conformation of the cation is 6.5 kcal/mol higher in energy than the local minimum, which has a very similar conformation. The global minimum-energy conformation is 0.7 kcal/mol lower in energy and has slightly different orientations of the morpholine and piperidine rings. Intermolecular interactions thus help determine the solid-state conformation.

The crystal structure (Figure 7) consists of stacks of molecules along the b-axis. The mean plane of the fused ring system is approximately −2,11,12. The Mercury Aromatics Analyser indicates one moderate interaction between the fused ring systems, at 5.25 Å, and three weak interactions.

Figure 7.

The crystal structure of alectinib hydrochloride is viewed down the b-axis. The image is generated using Diamond (Crystal Impact, 2023).

Analysis of the contributions to the total crystal energy of the structure using the Forcite module of Materials Studio (Dassault Systèmes, 2022) suggests that the intramolecular energy is dominated by angle distortion terms, as expected for a molecule containing a fused ring system. The intermolecular energy is dominated by electrostatic attractions, which, in this force field analysis, include hydrogen bonds. The hydrogen bonds are better analyzed using the results of the DFT calculation.

The protonated N5 makes two strong discrete N–H⋯Cl hydrogen bonds to the chloride anion (Table I). These link the cations and anions into chains along the b-axis. Several C–H⋯Cl hydrogen bonds also link the cations and anions. Intra- and inter-molecular C–H⋯N and C–H⋯O hydrogen bonds also contribute to the lattice energy.

TABLE I.

Hydrogen bonds (CRYSTAL23) in alectinib hydrochloride.

a Intramolecular.

The volume enclosed by the Hirshfeld surface of alectinib hydrochloride (Figure 8, Hirshfeld, Reference Hirshfeld1977; Spackman et al., Reference Spackman, Turner, McKinnon, Wolff, Grimwood, Jayatilaka and Spackman2021) is 663.77 Å3, which is 98.57% of the unit cell volume. The packing density is thus fairly typical. The only significant close contacts (red in Figure 8) involve the hydrogen bonds. The volume/non-hydrogen atom is typical at 18.2 Å3.

Figure 8.

The Hirshfeld surface of alectinib hydrochloride. Intermolecular contacts longer than the sums of the van der Waals radii are colored blue, and contacts shorter than the sums of the radii are colored red. Contacts equal to the sums of radii are white. The image is generated using CrystalExplorer (Spackman et al., Reference Spackman, Turner, McKinnon, Wolff, Grimwood, Jayatilaka and Spackman2021).

The Bravais–Friedel–Donnay–Harker (Bravais, Reference Bravais1866; Friedel, Reference Friedel1907; Donnay and Harker, Reference Donnay and Harker1937) morphology suggests that we might expect roughly isotropic morphology for alectinib hydrochloride. A second-order spherical harmonic model was included in the refinement. The texture index was 1.009(0), indicating that the preferred orientation was not significant in this rotated capillary specimen.

IV. DEPOSITED DATA

The powder pattern of alectinib hydrochloride from this synchrotron data set has been submitted to ICDD for inclusion in the Powder Diffraction File. The Crystallographic Information Framework (CIF) files containing the results of the Rietveld refinement (including the raw data) and the DFT geometry optimization were deposited with the ICDD. The data can be requested at .

ACKNOWLEDGEMENTS

Use of the Advanced Photon Source at the Argonne National Laboratory was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-06CH11357. This work was partially supported by the International Centre for Diffraction Data. We thank Saul Lapidus for his assistance in the data collection.

CONFLICTS OF INTEREST

The authors have no conflicts of interest to declare.

References

REFERENCES

Altomare, A., Cuocci, C., Giacovazzo, C., Moliterni, A., Rizzi, R., Corriero, N., and Falcicchio, A.. 2013. “EXPO2013: A Kit of Tools for Phasing Crystal Structures from Powder Data.” Journal of Applied Crystallography 46: 1231–5.10.1107/S0021889813013113CrossRefGoogle Scholar
Antao, S. M., Hassan, I., Wang, J., Lee, P. L., and Toby, B. H.. 2008. “State-of-the-Art High-Resolution Powder X-ray Diffraction (HRPXRD) Illustrated with Rietveld Refinement of Quartz, Sodalite, Tremolite, and Meionite.” Canadian Mineralogist 46: 1501–9.10.3749/canmin.46.5.1501CrossRefGoogle Scholar
Bravais, A. 1866. Etudes Cristallographiques. Paris, Gauthier Villars.Google Scholar
Bruno, I. J., Cole, J. C., Kessler, M., Luo, J., Motherwell, W. D. S., Purkis, L. H., Smith, B. R., Taylor, R., Cooper, R. I., Harris, S. E., and Orpen, A. G.. 2004. “Retrieval of Crystallographically-Derived Molecular Geometry Information.” Journal of Chemical Information and Computer Sciences 44: 2133–44.10.1021/ci049780bCrossRefGoogle ScholarPubMed
Crystal Impact. 2023. Diamond. V. 5.0.0. Crystal Impact – Dr. H. Putz & Dr. K. Brandenburg.Google Scholar
Dassault Systèmes. 2022. Materials Studio 2023. San Diego, CA, BIOVIA.Google Scholar
Donnay, J. D. H., and Harker, D.. 1937. “A New Law of Crystal Morphology Extending the Law of Bravais.” American Mineralogist 22: 446–47.Google Scholar
Erba, A., Desmarais, J. K., Casassa, S., Civalleri, B., Donà, L., Bush, I. J., Searle, B., Maschio, L., Daga, L.-E., Cossard, A., Ribaldone, C., Ascrizzi, E., Marana, N. L., Flament, J.-P., and Kirtman, B.. 2023. “CRYSTAL23: A Program for Computational Solid State Physics and Chemistry.” Journal of Chemical Theory and Computation 19: 6891–932. doi:10.1021/acs.jctc.2c00958.CrossRefGoogle ScholarPubMed
Friedel, G. 1907. “Etudes sur la loi de Bravais.” Bulletin de la Société Française de Minéralogie 30: 326–455.10.3406/bulmi.1907.2820CrossRefGoogle Scholar
Gates-Rector, S., and Blanton, T. N.. 2019. “The Powder Diffraction File: A Quality Materials Characterization Database.” Powder Diffraction 39: 352–60.10.1017/S0885715619000812CrossRefGoogle Scholar
Gatti, C., Saunders, V. R., and Roetti, C.. 1994. “Crystal-Field Effects on the Topological Properties of the Electron-Density in Molecular Crystals – the Case of Urea.” Journal of Chemical Physics 101: 10686–96.10.1063/1.467882CrossRefGoogle Scholar
Groom, C. R., Bruno, I. J., Lightfoot, M. P., and Ward, S. C.. 2016. “The Cambridge Structural Database.” Acta Crystallographica Section B: Structural Science, Crystal Engineering and Materials 72: 171–9.10.1107/S2052520616003954CrossRefGoogle ScholarPubMed
Hirshfeld, F. L. 1977. “Bonded-Atom Fragments for Describing Molecular Charge Densities.” Theoretica Chemica Acta 44: 129–38.10.1007/BF00549096CrossRefGoogle Scholar
Kaduk, J. A., Crowder, C. E., Zhong, K., Fawcett, T. G., and Suchomel, M. R.. 2014. “Crystal Structure of Atomoxetine Hydrochloride (Strattera), C17H22NOCl.” Powder Diffraction 29: 269–73.10.1017/S0885715614000517CrossRefGoogle Scholar
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., Zaslavsky, L., Zhang, J., and Bolton, E. E.. 2023. “Pubchem 2023 update.” Nucleic Acids Research 51 (D1): D1373–80. doi:10.1093/nar/gkac956.CrossRefGoogle ScholarPubMed
Kresse, G., and Furthmüller, J.. 1996. “Efficiency of Ab-Initio Total Energy Calculations for Metals and Semiconductors Using a Plane-Wave Basis Set.” Computational Materials Science 6: 15–50.10.1016/0927-0256(96)00008-0CrossRefGoogle Scholar
Lee, P. L., Shu, D., Ramanathan, M., Preissner, C., Wang, J., Beno, M. A., Von Dreele, R. B., Ribaud, L., Kurtz, C., Antao, S. M., Jiao, X., and Toby, B. H.. 2008. “A Twelve-Analyzer Detector System for High-Resolution Powder Diffraction.” Journal of Synchrotron Radiation 15: 427–32.10.1107/S0909049508018438CrossRefGoogle ScholarPubMed
Macrae, C. F., Sovago, I., Cottrell, S. J., Galek, P. T. A., McCabe, P., Pidcock, E., Platings, M., Shields, G. P., Stevens, J. S., Towler, M., and Wood, P. A.. 2020. “Mercury 4.0: From Visualization to Design and Prediction.” Journal of Applied Crystallography 53: 226–35.10.1107/S1600576719014092CrossRefGoogle ScholarPubMed
Materials Design. 2016. MedeA 2.20.4. Angel Fire, NM, Materials Design Inc.Google Scholar
MDI. 2023. JADE Pro Version 8.3. Livermore, CA, Materials Data.Google Scholar
Peintinger, M. F., Vilela Oliveira, D., and Bredow, T.. 2013. “Consistent Gaussian Basis Sets of Triple-Zeta Valence with Polarization quality for Solid-State Calculations.” Journal of Computational Chemistry 34: 451–9.10.1002/jcc.23153CrossRefGoogle ScholarPubMed
Silk Scientific. 2013. UN-SCAN-IT 7.0. Orem, UT, Silk Scientific Corporation.Google Scholar
Spackman, P. R., Turner, M. J., McKinnon, J. J., Wolff, S. K., Grimwood, D. J., Jayatilaka, D., and Spackman, M. A.. 2021. “Crystalexplorer: A Program for Hirshfeld Surface Analysis, Visualization and Quantitative Analysis of Molecular Crystals.” Journal of Applied Crystallography 54: 1006–11. doi:10.1107/S1600576721002910.CrossRefGoogle ScholarPubMed
Stephens, P. W. 1999. “Phenomenological Model of Anisotropic Peak Broadening in Powder Diffraction.” Journal of Applied Crystallography 32: 281–9.10.1107/S0021889898006001CrossRefGoogle Scholar
Sykes, R. A., McCabe, P., Allen, F. H., Battle, G. M., Bruno, I. J., and Wood, P. A.. 2011. “New Software for Statistical Analysis of Cambridge Structural Database Data.” Journal of Applied Crystallography 44: 882–6.10.1107/S0021889811014622CrossRefGoogle Scholar
Tanaka, K., and Ueto, T.. 2019. “Novel Crystal of Tetracyclic Compound.” European Patent EP3135671 B1.Google Scholar
Toby, B. H., and Von Dreele, R. B.. 2013. “GSAS II: The Genesis of a Modern Open Source All Purpose Crystallography Software Package.” Journal of Applied Crystallography 46: 544–9.10.1107/S0021889813003531CrossRefGoogle Scholar
Tomar, V. S., Azim, A., Gupta, N., Lahiri, S., and Cabri, W.. 2019. “A Process for Preparing Alectinib or a Pharmaceutically Acceptable Salt Thereof.” International Patent Application WO2019/008520 A1.Google Scholar
Tomar, V. S., Azim, A., Gupta, N., Lahiri, S., and Cabri, W.. 2020. “A Process for Preparing Alectinib or a Pharmaceutically Acceptable Salt Thereof.” United States Patent Application US2020/0140427 A1.Google Scholar
van de Streek, J., and Neumann, M. A.. 2014. “Validation of Molecular Crystal Structures from Powder Diffraction Data with Dispersion-Corrected Density Functional Theory (DFT-D).” Acta Crystallographica Section B: Structural Science, Crystal Engineering and Materials 70: 1020–32.10.1107/S2052520614022902CrossRefGoogle ScholarPubMed
Wang, J., Toby, B. H., Lee, P. L., Ribaud, L., Antao, S. M., Kurtz, C., Ramanathan, M., Von Dreele, R. B., and Beno, M. A.. 2008. “A Dedicated Powder Diffraction Beamline at the Advanced Photon Source: Commissioning and Early Operational Results.” Review of Scientific Instruments 79: 085105.10.1063/1.2969260CrossRefGoogle ScholarPubMed
Wavefunction, Inc. 2022. Spartan ‘20. V. 1.1.4. Irvine, CA, Wavefunction Inc.Google Scholar
Figure 0

Figure 1. The two-dimensional structure of alectinib hydrochloride.

Figure 1

Figure 2. X-ray powder diffraction patterns of crystalline Type I (black), II (green), and III (red) of alectinib hydrochloride from European Patent EP3135671 B1 (Tanaka and Ueto, 2019; Chugai Seiyaku Kabushiki Kaisha). The patent patterns (measured using Cu Kα radiation) were digitized using UN-SCAN-IT (Silk Scientific, 2013). The image is generated using JADE Pro (MDI, 2023).

Figure 2

Figure 3. The Rietveld plot for the refinement of alectinib hydrochloride. The blue crosses represent the observed data points, and the green line is the calculated pattern. The cyan curve is the normalized error plot, and the red line is the background curve. The vertical scale has been multiplied by a factor of 20× for 2θ > 15.0°.

Figure 3

Figure 4. Comparison of the synchrotron pattern of alectinib hydrochloride from this study (black) to that of Form I from European Patent EP3135671 B1 (Tanaka and Ueto, 2019; Chugai Seiyaku Kabushiki Kaisha, green). The patent pattern (measured using Cu Kα radiation) was digitized using UN-SCAN-IT (Silk Scientific, 2013) and converted to the synchrotron wavelength of 0.459744 Å using JADE Pro (MDI, 2023). The image is generated using JADE Pro (MDI, 2023).

Figure 4

Figure 5. The asymmetric unit of alectinib hydrochloride is depicted, with the atom numbering included. The atoms are represented by 50% probability spheroids/ellipsoids. The image is generated using Mercury (Macrae et al., 2020).

Figure 5

Figure 6. Comparison of the Rietveld-refined (red) and CRYSTAL23-optimized (blue) structures of alectinib hydrochloride. The rms Cartesian displacement for the cation is 0.181 Å. The image is generated using Mercury (Macrae et al., 2020).

Figure 6

Figure 7. The crystal structure of alectinib hydrochloride is viewed down the b-axis. The image is generated using Diamond (Crystal Impact, 2023).

Figure 7

TABLE I. Hydrogen bonds (CRYSTAL23) in alectinib hydrochloride.

Figure 8

Figure 8. The Hirshfeld surface of alectinib hydrochloride. Intermolecular contacts longer than the sums of the van der Waals radii are colored blue, and contacts shorter than the sums of the radii are colored red. Contacts equal to the sums of radii are white. The image is generated using CrystalExplorer (Spackman et al., 2021).